ETX.L Regulatory News (ETX)

4 Apr 2008 14:38

e-Therapeutics plc04 April 2008 e-Therapeutics plc (the "Company") Director's Holding in the Company The Company was notified on 4 April 2008 that the partner of John Cordiner,Commercial and Finance Director, acquired 9,190 ordinary shares of 0.1 penceeach in the capital of the Company ("Ordinary Shares") on 2 April 2008 at aprice of 54 pence per Ordinary Share. The Company was also notified on 4 April 2008 that John Cordiner acquired 8,000Ordinary Shares on 2 April 2008 at a price of 58 pence per Ordinary Share.Following these acquisitions, John Cordiner has a total notifiable interest of371,250 Ordinary Shares, representing 0.67% of the issued share capital of theCompany. For further information, please contact: e-Therapeutics plcJohn Cordiner 0191 233 1317 WH Ireland LimitedRichard Lindley 0113 394 6628 This information is provided by RNS The company news service from the London Stock Exchange